UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
_______________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): October 28, 2009
ADVAXIS,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State or
other jurisdiction of incorporation)
00028489
|
02-0563870
|
(Commission
File Number)
|
(IRS
Employer Identification Number)
|
Technology
Centre of New Jersey
675
Rt. 1, Suite B113
North
Brunswick, N.J. 08902
(Address
of principal executive offices)
Registrant’s
telephone number, including area code: (732) 545-1590
Not
applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01. Other Events.
On
October 28, 2009, Advaxis, Inc. (the “Company”) issued a press release regarding
its bridge financing transaction. A copy of the press release, which
is attached as Exhibit 99.1 to this Current Report, is incorporated herein by
reference.
On
October 29, 2009, the Company gave a presentation at the 8th Annual
Bio Investors Forum. The investor presentation materials are
incorporated herein by reference, and are attached as Exhibit 99.2 to this
Current Report.
Item
9.01 Financial Statements and Exhibits.
(c)
|
Exhibits
|
|
|
99.1
|
Advaxis,
Inc. press release, dated October 28, 2009.
|
|
|
99.2
|
Investor
Presentation materials.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: November
3,
2009
|
Advaxis, Inc. |
|
|
|
|
|
|
By:
|
/s/ Fredrick
D. Cobb |
|
|
|
Fredrick
D. Cobb, Vice President, Finance and
Principal
Financial Officer
|
|
|
|
|
|
|
|
|
|
EXHIBIT
INDEX
Exhibit
No.
|
Document
Description
|
|
|
99.1
|
Advaxis,
Inc. press release, dated October 28, 2009.
|
|
|
99.2
|
Investor
Presentation materials.
|
|
|